Cargando…
A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients
OBJECTIVE: Previous studies have suggested that variations in the ABCC8 gene may be closely associated with T2DM susceptibility and repaglinide response. However, these results have not been entirely consistent, and there are no related studies in a Chinese population, suggesting the need for furthe...
Autores principales: | Zhou, Xueyan, Chen, Chunxia, Yin, Di, Zhao, Feng, Bao, Zejun, Zhao, Yun, Wang, Xi, Li, Wei, Wang, Tao, Jin, Yingliang, Lv, Dongmei, Lu, Qian, Yin, Xiaoxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746626/ https://www.ncbi.nlm.nih.gov/pubmed/31118371 http://dx.doi.org/10.2169/internalmedicine.2133-18 |
Ejemplares similares
-
A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients
por: Zhou, Xueyan, et al.
Publicado: (2016) -
The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
por: Guardado-Mendoza, Rodolfo, et al.
Publicado: (2013) -
MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus
por: Wang, Tao, et al.
Publicado: (2019) -
Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus
por: Younas, Amna, et al.
Publicado: (2021) -
Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
por: Ma, J., et al.
Publicado: (2014)